Kinetics of Inclusion Body Formation and Its Correlation with the Characteristics of Protein Aggregates in Escherichia coli by Upadhyay, Arun K. et al.
Kinetics of Inclusion Body Formation and Its Correlation
with the Characteristics of Protein Aggregates in
Escherichia coli
Arun K. Upadhyay, Aruna Murmu, Anupam Singh, Amulya K. Panda*
Product Development Cell, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India
Abstract
The objective of the research was to understand the structural determinants governing protein aggregation into inclusion
bodies during expression of recombinant proteins in Escherichia coli. Recombinant human growth hormone (hGH) and
asparaginase were expressed as inclusion bodies in E.coli and the kinetics of aggregate formation was analyzed in details.
Asparaginase inclusion bodies were of smaller size (200 nm) and the size of the aggregates did not increase with
induction time. In contrast, the seeding and growth behavior of hGH inclusion bodies were found to be sequential,
kinetically stable and the aggregate size increased from 200 to 800 nm with induction time. Human growth hormone
inclusion bodies showed higher resistance to denaturants and proteinase K degradation in comparison to those of
asparaginase inclusion bodies. Asparaginase inclusion bodies were completely solubilized at 2–3 M urea concentration
and could be refolded into active protein, whereas 7 M urea was required for complete solubilization of hGH inclusion
bodies. Both hGH and asparaginase inclusion bodies showed binding with amyloid specific dyes. In spite of its low b-sheet
content, binding with dyes was more prominent in case of hGH inclusion bodies than that of asparaginase. Arrangements
of protein molecules present in the surface as well as in the core of inclusion bodies were similar. Hydrophobic
interactions between partially folded amphiphillic and hydrophobic alpha-helices were found to be one of the main
determinants of hGH inclusion body formation. Aggregation behavior of the protein molecules decides the nature and
properties of inclusion bodies.
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Introduction
Inclusion bodies (IBs) are formed during high level expression of
heterologous proteins in E. coli [1,2]. These are often localized in
cytoplasm or periplasm of the expression hosts and seen as dense
refractile aggregates under electron microscope [3,4]. Aggregation
of proteins during high level expression is generally attributed to
high local concentration of naive polypeptide chains emerging
from ribosomes, inefficient folding and unavailability of chaper-
ones [5,6]. These factors lead to the formation of partially folded
or misfolded protein intermediates in cytoplasm. Usually, these
intermediates have surface exposed hydrophobic patches which
come together to form large, amorphous inclusion body (IB)
aggregates [7]. Isolation of bioactive protein from inclusion bodies
is cumbersome and needs understanding of protein aggregation
behavior [8,9]. Although IBs have been characterized as
amorphous aggregates, they are not merely a cluster of disordered
folding intermediates [10,11]. Rather, inclusion body proteins are
often enriched in b-sheet structures [12–15] and bind to amyloid
specific dyes like Thioflavin-T and Congo-Red [14,16–18].
Moreover, inclusion bodies have ability to seed aggregation of
structurally similar proteins, a characteristic property of amyloids
[14]. Aggregation leading to inclusion body formation has been
reported to be very specific in nature as they mostly consist of the
expressed recombinant proteins [16,19]. Size distribution of IB
aggregates, as well as their other physical and structural properties
depends on cultivation and induction conditions [20,21]. Revers-
ibility of inclusion body formation [22] and existence of native-like
structure of proteins in inclusion bodies has also been reported
[12–13,23–24]. Besides this, there are reports suggesting the
presence of biologically active protein molecules in inclusion bodies
[25–28]. Inclusion body aggregates formed at lower temperature
have fully functional bioactive proteins and are called as non-
classical inclusion bodies whereas tough, protease resistant aggre-
gates are called as classical inclusion bodies [29,30]. However,
inclusion bodies produced at higher temperature has been reported
to have functional protein in them [31]. The formation of insoluble
aggregates of recombinant proteins during high level expression is
driven by the association of partially folded or misfolded
intermediates. These aggregates have been thought to be resistant
to proteases and solubilized only in high molar concentration of
chaotropes. It has also been reported that inclusion body aggregates
can be solubilized using mild solubilization agent without disturbing
the native-like secondary structures of proteins [32–34].
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inclusion bodies as a consequence of the self assembly of non-
native monomers into growing polymers of higher sizes [35]. The
first model proposes that inclusion body aggregation proceeds
from a single or limited number of nucleation sites by
accumulation of misfolded intermediates. As these nucleation
aggregates are thermodynamically stable entities, the addition of
misfolded monomers on these aggregates are favored. The second
model treats IBs as aggregate of aggregates in which small size
aggregates tend to associate themselves to give rise to one or more
bigger aggregates. In spite of the availability of a large amount of
literature on inclusion body formation, the mechanism of inclusion
body formation and the nature of intermediates involved in
different types of aggregates are still not clear.
In present work, Human growth hormone (hGH) and E. coli L-
asparaginase II, were cloned and expressed as IBs in E. coli.
Kinetics of inclusion body formation, their morphological and
structural characteristics were studied by transmission electron
microscopy (TEM), size distribution analysis, proteolytic degrada-
tion, solubilization, Congo Red and Th-T dye binding assays, and
FTIR spectroscopy. The objective was to unravel the aggregation
behavior of different proteins expressed as inclusion bodies in E.
coli so that improved method for their solubilization could be
developed for high throughput recovery of bioactive protein.
Results
Proteinase K degradation profiles of asparaginase and
hGH inclusion bodies
To understand the differential physical properties of different
inclusion body aggregates, proteolytic susceptibilities of the recom-
binant hGH and asparaginase inclusion bodies expressed in E. coli
were analyzed. Both the proteins were expressed as inclusion bodies
and purified by sucrose density gradient ultracentrifugation (Fig. 1a).
In spite of its low molecular weight, hGH inclusion bodies were
denser (tube 2 in Fig. 1a) in comparison to the asparaginase inclusion
bodies (tube 1 in Fig. 1a). Asparaginase and hGH were expressed as
37 kDa and 21 kDa protein respectively as shown in SDS-PAGE
(Fig. 1b). The purified inclusion bodies were subjected to proteinase
K treatment which indicated differential susceptibilities of these IBs to
proteinase K (Fig. 1c). Inclusion bodies of hGH were found to be
resistant to proteinase K whereas asparaginase IBs were highly prone
to proteinase K attack. In 20 minutes, 80% of asparaginase IBs was
degraded whereas only 20% degradation was observed for hGH IBs.
This apparently indicated the tough and compact nature of hGH
inclusion bodies in comparison to those of asparaginase inclusion
bodies. This was further confirmed by the denaturation profiles of
hGH (Fig. 1d) and asparaginase IBs (Fig. 1e) at different
concentrations of urea. Complete solubilization of hGH IBs occurred
at 7 molar urea concentration. However, just 2–3 molar urea was
found to be sufficient for complete solubilization of asparaginase IBs.
Furthermore, asparaginase IBs solubilized in 3 M urea and refolded
by pulsatiledilution method resulted in bioactive protein. The activity
was comparable to the asparaginase refolded after solubilization in
6 M or 8 M urea (Fig. 2). This information suggested the soft and
delicate nature of asparaginase IBs in comparison to dense and
compact nature of hGH inclusion bodies. It can be concluded that
hGH inclusion bodies were of classical type whereas asparaginase was
expressed as non-classical inclusion bodies.
Kinetic of inclusion body formation by size analysis of
protein aggregates
Kinetics of inclusion body formation with induction time, exact
mechanism of nucleation and growth of inclusion body
aggregates are not well understood. To understand this, sizes of
IBs isolated from E. coli cells harvested at different time points (1,
2, 3 and 4 hours duration) after induction were analyzed. Ultra
pure IBs from these E. coli cells were isolated by procedures as
described in materials and methods. Size distribution patterns of
hGH and asparaginase IBs analyzed by particle sizer are
presented in Figure 3. Size distribution pattern of asparaginase
IBs remained same for four hours duration after induction
(Fig. 3a). Most of the asparaginase IBs sizes were in range of 100–
200 nm sizes. There were no distinct nucleation and growth
phases present within the shortest possible time limit of
60 minutes after induction. However the size of hGH inclusion
bodies increased progressively and saturated at around 4 hours
after induction (Fig. 3b). After 4 hours of induction, most of the
hGH inclusion bodies were around 200–800 nm with very less
proportion having size less than 100 nm. This was also supported
by transmission electron micrographs of these IBs. Size of pure
asparaginase IBs isolated after different time points of IPTG
induction was almost same (Fig. 4). However, there were
approximately 15% aggregates in range of 20–40 nm in inclusion
body preparations of different post induction periods. The
expression level of asparaginase saturated only after four hours
of IPTG induction while inclusion body size saturated within
60 minutes after induction. The size of aggregates could have
increased after 60 minutes of induction if newly synthesized
polypeptide chains would have been deposited on the same seed
in a single cell. But it was contrary to size distribution result
obtained for asparaginase IBs. Thus, it can be concluded that
multiple nucleation seeds were formed in a single cell of E. coli
during expression of recombinant asparaginase. The growth of
these seeds occurred for short duration and got saturated within
1 hour and further new seeds were formed during protein
expression.
In contrast, size distribution pattern of hGH inclusion bodies
formed after induction for different durations, indicated the
presence of distinct nucleation and growth phases during IB
formation (Fig. 3b). The maximum size of IBs after 4 hours of
IPTG induction was in range of 200 to 800 nm. The seeding of
aggregation started immediately after induction and there was
gradual increase in size of IB aggregates till 3 hours of post
induction period (Fig. 3b). The increase in size of IB aggregates
was highest between 2–3 hours of post induction period. After one
hour of induction, 90% of IB aggregates were of smaller size (25–
150 nm). With increase in post induction period, the population of
these smaller size IBs was reduced to 65% at 2 hours and at the
end of 3 hours after induction, just 10% IB aggregates were found
to be smaller than 150 nm. This indicated that hGH IB formation
starts immediately after induction, aggregation seeds are formed
and they grow in size continuously during expression period.
Increase in size of hGH inclusion bodies at different time points
after induction was also confirmed by TEM analyses (Fig. 5).
Thus, it can be concluded that different proteins follow different
aggregation mechanisms during recombinant protein expression
in E. coli. Expression of asparaginase in E. coli leads to the
formation of large number of aggresomes (small aggregates) in a
single cell which loosely associate amongst themselves to form
bigger aggregates. While expression of hGH IBs in E. coli results in
the formation of single large aggregate in a cell by continuous
deposition of protein molecules on a nucleation seed. The
proteolytic digestion and solubilization profile of hGH and
asparaginase IBs were in agreement with size distribution pattern.
Tough and large IBs are formed by sequential deposition whereas
soft and small IB aggregates are formed immediately after IPTG
induction.
Protein Structure inside Inclusion Bodies
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33951Figure 1. Purification, proteolytic digestion and solubilization profile of human growth hormone and asparaginase inclusion
bodies. (a) Purification of inclusion bodies by sucrose density gradient ultracentrifugation, tube one : asparaginase IB, tube two: hGH inclusion
bodies (b) SDS-PAGE analysis of purified hGH (21 kDa, lane 1) and asparaginase (37 kDa, lane 3) inclusion bodies. Lane 2 and 4, LMW marker: 97, 66,
45, 30, 20.1 and 14.4 kDa. (c) Kinetics of proteolytic digestion of inclusion body aggregates by Proteinase K. SDS-PAGE of solubilized inclusion body
supernatants. (d) hGH IBs. Lane 1–9, supernatants of 0 to 8 molar urea. (e) Asparaginase IBs. Lane 1–9, supernatants of 0 to 8 molar urea; lane M, LMW
marker (97, 66, 45, 30, 20.1 and 14.4 kDa).
doi:10.1371/journal.pone.0033951.g001
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bodies harvested after different induction time
To measure the extent of compactness of protein aggregates in
inclusion bodies, purified IBs were subjected to different
denaturing conditions and proteinase K digestion. Solubilization
profile of hGH and asparaginase inclusion bodies in different
molar concentrations of urea was determined by measuring the
turbidity of solubilized samples at 350 nm (Fig. 6). It was observed
that hGH inclusion bodies were progressively more soluble with
increasing urea concentration from 1–8 M (Fig. 6a). Complete
solubilization of inclusion body aggregates occurred at 7 M urea
solution. Interestingly, the solubility of proteins from inclusion
Figure 2. Relative activities of refolded asparaginase after
solubilization of asparaginase IBs in different concentrations
of urea.
doi:10.1371/journal.pone.0033951.g002
Figure 3. Size distribution patterns of IBs isolated from E. coli
cells harvested at different time points after induction. (a)
Asparaginase IBs. (b) hGH IBs. Colored bars indicate the harvesting time.
doi:10.1371/journal.pone.0033951.g003
Figure 4. Transmission electron micrograph of purified aspa-
raginase inclusion bodies. (a), (b), (c) and (d) asparaginase IBs
isolated after 1, 2, 3 and 4 hours of IPTG induction respectively. Bar
represents 2 mm.
doi:10.1371/journal.pone.0033951.g004
Figure 5. Transmission electron micrograph of purified hGH
inclusion bodies. (a), (b), (c) and (d) are hGH IBs isolated after 1, 2, 3
and 4 hours of IPTG induction respectively. Bar represents 2 mm.
doi:10.1371/journal.pone.0033951.g005
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comparison to those isolated at 2–4 hours after induction
(Fig. 6a). However smaller sized inclusion bodies of hGH isolated
after early hour of induction were not soluble in low concentration
of urea as observed for asparaginase. In contrast, asparaginase
inclusion bodies were completely soluble in 2–3 molar urea
concentration (Fig. 6b). For asparaginase, solubilization pattern of
IB proteins in different molar concentrations of urea was
independent of harvest time after IPTG induction (Fig. 6b).
This difference in solubilization profile of hGH inclusion bodies
isolated from cells harvested at different time points after induction
could be due to differences in composition of IB aggregates. The
smaller inclusion body aggregates (isolated after 1 hour of
induction) got solubilized at slightly lower concentration of urea
owing to their large accessible surface area. However, this
possibility can be negated as sufficient time was given for
solubilization of these IBs. Thus, it can be inferred that increase
in post induction period makes hGH inclusion bodies more
resistant to denaturants. Similar results were obtained from
proteinase K degradation study (Fig. 7). Asparaginase inclusion
bodies were found to be very prone to proteinase K attack and
there was no effect of post induction time on susceptibility of these
inclusion bodies to proteinase K degradation (Fig. 7a). Asparag-
inase inclusion bodies showed steep slope for denaturant based
solubilization and proteinase K digestion. Proteinase K digestion
required less time to degrade asparaginase inclusion bodies. This
inferred that the stabilizing forces between aggregating species in
asparaginase inclusion bodies are weak and unstable. Removal of
molecules from the asparaginase IB surface during solubilization
was rapid and occurred within a narrow range of urea
concentration. However, hGH inclusion bodies isolated after
1 hour of induction were more prone to proteinase K degradation
in comparison to inclusion bodies isolated after 2, 3 and 4 hours of
post induction (Fig. 7b). There was gradual decrease in
susceptibility of human growth hormone IBs to proteinase K with
increase in post induction time. Human growth hormone inclusion
bodies were more compact and required higher concentration of
denaturant for complete solubilization. The concentrations of urea
for 50% solubilization of hGH inclusion bodies isolated at 1, 2, 3,
and 4 hours of post induction were found to be 4.7 M, 4.95 M,
5.2 M and 5.5 M respectively. This showed that the compactness
and strength of interaction between aggregating species in hGH
inclusion bodies increased with increase in post induction time. No
such changes were observed in case of asparaginase inclusion
bodies. Solubilization and proteolytic data inferred that not only
the size but also the quality of asparaginase inclusion body
aggregates do not change with increase in post induction time.
Homogeneity in arrangement of protein molecules in inclusion
bodies was deduced by calculating the change in rate of proteolytic
degradation of IBs with time. It was of great interest to know
whether there is any difference between the arrangement of
protein molecules present in the core and the peripheral regions of
IB aggregates. Proteinase K degradation pattern of IBs isolated
Figure 6. Solubilization profiles of inclusion bodies isolated
from cell harvested at different time points after induction. (a)
hGH IBs (b) Asparaginase IBs. Colored bars indicate the harvesting time.
doi:10.1371/journal.pone.0033951.g006
Figure 7. Proteinase K degradation profiles of inclusion bodies
isolated from E. coli cells harvested at different time points
after induction. (a) Asparaginase IBs. (b) hGH IBs. Colored bars
indicate the harvesting time.
doi:10.1371/journal.pone.0033951.g007
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graph of proteinase K digestion of IBs revealed that the rate of
degradation decreased with reaction time (Fig. 8a). This could be
either due to the compact nature of inner layers of IBs which get
exposed after removal of upper layers or this may be due to
decreased IB concentration (as it acts as a substrate for proteinase
K, continuous conversion of inclusion body aggregates into
degraded fragments during reaction will decrease the substrate
concentration, thus reaction rate). To find out the possible reason
for this degradation pattern, rate of change in degradation rate
was plotted with respect to turbidity (i.e. substrate concentration)
of inclusion bodies measured at 350 nm at different time points of
reaction (Fig. 8b). The rate of change of degradation rate was
negligible with respect to substrate concentration. It can only be
possible in an enzyme catalyzed reaction if substrates (IBs) are
similar in nature. Thus, it can be concluded that smaller
aggregates which form during proteinase K degradation have
similar morphology and topology as intact IBs and there is no
difference in arrangement of protein molecules present in core and
peripheral regions of both asparaginase and hGH inclusion bodies.
Binding of amyloid specific dyes to inclusion bodies
It has been observed that amyloid fibrils interact specifically
with Congo red (CR) dye which depends on secondary structure of
interacting entities of fibril, especially b-pleated sheet conforma-
tion [36]. The cross b-sheet conformation of amyloids appears to
be the crucial factor in CR binding. Other proteins that lack or
contain only minor proportion of b-sheet structure do not stain
with CR [37–38]. The interaction of amyloids with CR also
induces shift in the characteristic spectrum of CR which depends
on the nature of aggregate conformation. Inclusion body
aggregates consist of partially ordered secondary structures and
there are reports indicating the binding of IBs with CR dye
[14,16–18]. Therefore, binding of IBs to CR was analyzed to study
their amyloidogenic nature. CR alone exhibits absorption
maximum at 490 nm, which shifts to higher wavelength once it
binds to amyloid material. Asparaginase and hGH IBs isolated at
different time points after induction promoted a strong red shift in
the absorption maxima (Fig. 9). The difference spectra showed
broad peaks at 565 nm for asparaginase IBs and at 560 nm for
hGH IBs. However, absorbance of CR with IBs isolated at early
time point of post induction was less in comparison to that of
inclusion bodies harvested after later time points. The absorbance
of CR bound hGH IBs was higher than that of asparaginase IBs
indicating that hGH IBs are more amyloidogenic in nature in
comparison to asparaginase IBs.
These results were also supported by thioflavin-T (Th-T)
binding, which is an amyloid specific fluorescent dye. Thiofla-
vin-T also undergoes characteristic spectral alteration on binding
to amyloid aggregates, which does not occur on binding to the
precursor polypeptides, monomers, or amorphous aggregates of
peptides and proteins [39,40]. Binding of amyloid fibril with Th-T
alters excitation and emission maxima of dye. Emission maxima
for hGH and asparaginase IBs were around 475 nm and 485 nm.
Figure 8. Proteinase K degradation profiles of hGH and
asparaginase inclusion bodies isolated after 4 hours of induc-
tion. (a) Rate of degradation of IBs with time. (b) Rate of change in
degradation rate of IBs with decrease in turbidities.
doi:10.1371/journal.pone.0033951.g008
Figure 9. Spectral characteristics of Congo-Red (CR) and
difference spectra of IBs. (a) Asparaginase and (b) hGH inclusion
bodies isolated at different time points after induction. Concentrations
of CR and IBs used for assay were 10 mM and 25 mg/ml respectively.
doi:10.1371/journal.pone.0033951.g009
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440 nm and emission maxima at 482 nm. Binding to amyloid
aggregates result in large enhancement in fluorescence intensity of
Th-T. The binding of Th-T dye with hGH IBs brought sharp
increase in fluorescence intensity in comparison to asparaginase
IBs at equal protein concentrations (Fig. 10). It was observed that
increase in post induction period resulted in formation of hGH
inclusion bodies which showed stronger binding to Th-T dye.
Asparaginase inclusion bodies isolated at different time points after
induction had similar binding strength with Th-T. The difference
in CR and Th-T binding to asparaginase and hGH inclusion
bodies could be either due to variation in arrangement of protein
molecules inside inclusion body aggregates or due to the types and
proportion of secondary structural elements present in IBs.
Structural analysis of inclusion body proteins by FTIR
spectroscopy
To find out the possible role of secondary structural elements of
hGH and asparaginase IBs in differential binding properties to CR
and Th-T dyes, their FTIR spectra were analyzed. Native hGH is
predominantly a helical protein with small number of loops and
turns, while asparaginase consists of both helices and b-sheets as
well as large number of loops and turns. Second derivative spectra
of native hGH [41] and hGH inclusion bodies showed that
formation of inclusion body aggregates lead to small increase in b-
sheet content (Fig. 11a). Second derivative spectra of hGH IBs
showed prominent peak area at 1654 cm
21, characteristics of a-
helices with small peak area at 1623 cm
21, characteristic of b-
sheet. In spite of small proportions of b-sheet content, hGH
inclusion bodies showed very strong binding with CR and Th-T
dyes. It was also found to be more resistant to proteolysis and
denaturation. From the amino acid sequence of helix forming
regions of hGH protein, it was observed that majority of them
consist of hydrophobic and amphipathic amino acid residues
(Table 1). These residues were present at regular intervals and
formed hydrophobic helices. These helices may interact strongly
and form very compact and hard aggregates. Moreover, the
formation of compact and insoluble aggregates does not
Figure 10. Spectral characteristics of Th-T binding with IBs. (a)
Asparaginase and (b) hGH inclusion bodies isolated at different time
points after induction. Concentrations of Th-T and IBs used for assay
were 75 mM and 50 mg/ml respectively.
doi:10.1371/journal.pone.0033951.g010
Figure 11. Second derivative FTIR spectra of hGH and
asparaginase IBs. (a) Second derivative spectrum of hGH IBs. (b)
Second derivative spectrum of asparaginase IBs in amide band region.
Broader peak in 1620–1640 cm-1 and 1680–1685 cm-1 range indicates
large beta sheet content.
doi:10.1371/journal.pone.0033951.g011
Table 1. Amino acid sequence of hGH (Swiss-Prot, P01241).
.sp|P01241|SOMA_HUMAN Somatotropin
OS=Homo sapiens
MATGSRTSLLLAFGLLCLPWLQEGSAFPTIPLSRLFDNAMLRAHRLHQLAFDTYQEF
EEAYIPKEQKYSFLQNPQTSLCFSESIPTPSNREETQQSNLELLRISLLLIQSWLEPVQF
LRSVFANSLVYGASDSNVYDLLKDLEEGIQTLMGRLEDGSPRTGQIFKQTYSKFDTN
SHNDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVEGSCGF
Bold and italics regions indicate presence of hydrophobic residues involves in
making hydrophobic and amphipathic helices.
doi:10.1371/journal.pone.0033951.t001
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formed by strong interaction between amphipathic or hydropho-
bic helices. FTIR spectra of asparaginase IBs revealed the
presence of significantly large proportion of b-sheet content in
IBs (Fig. 11b) in comparison to native protein [42]. The crystal
structure of asparaginase also entails that the protein is rich in b-
pleated secondary structures (Swissprot, P00805, PDBe:3eca).
Crystal structure of asparaginase and b-sheet content present in
IBs, shown by FTIR spectra (Fig. 11b), are in accordance to its
binding properties to amyloid specific dyes. The soft and
denaturation prone nature of asparaginase IBs can be due to
irregular arrangement of its b-sheet regions, leaving large
accessible areas to proteases and denaturants for action.
Discussion
Formation of inclusion body aggregates imposes a severe
challenge in purification of bioactive recombinant protein from
E. coli. The information about structural and physical properties of
inclusion bodies during expression conditions is necessary for
developing mild solubilization procedures which may result in
improved recovery of bioactive protein. Better insight into the
structural and physical properties of inclusion bodies can help in
developing appropriate solubilization and refolding conditions
during purification of bioactive protein from inclusion bodies. The
present study reveals that depending on the aggregation properties
of proteins, different types of inclusion bodies are formed in E. coli.
Asparaginase IBs were around 100 nm in size whereas the size of
hGH IBs was in the range of 200–600 nm. Small sized inclusion
bodies are soft and are soluble in low concentration of urea where
as large size inclusion bodies are denser and require high molar
concentration of urea for complete solubilization. There was no
significant effect of post induction period on quality and size of
inclusion body aggregates for asparaginase where as for hGH the
inclusion bodies size increased along with induction time.
However, hGH inclusion bodies were tough and protease resistant
from the beginning. Present study also put forward variation in
kinetics of IB formation by different proteins. Proteins which form
softer and smaller aggregates showed continuous seeding during
expression period as contrary to the denser and harder IB forming
proteins. Amyloid specific dye binding assays reveals the
amyloidogenic nature of IB aggregates. Also, b-sheet conformation
was not found to be solely responsible for protein aggregation into
inclusion bodies as observed in the case hGH IBs. It is the
interactive forces associated with the secondary structural elements
of the protein that govern the aggregation kinetics leading to the
formation of different types of IB aggregates.
On the basis of solubility and presence of biological activity, IBs
have been categorized as classical and non-classical inclusion
bodies [29]. The non-classical inclusion bodies have high amount
of correctly folded target protein or its precursor and are produced
at lower temperature [30]. Our observations indicated non-
classical nature of asparaginase IBs and classical nature of hGH
IBs. It can be proposed that non-classical inclusion bodies are less
dense, soluble in mild denaturants concentration, susceptible to
protease attack, less amyloidogenic and have more defined protein
structure in it. Whereas classical inclusion bodies are denser,
tough, highly amyloidogenic, more resistant to protease attack,
and are only soluble in high molar concentration of chaotropes.
The mechanisms of inclusion body formation for recombinant
asparaginase and hGH are quite different. The seeding and
growth phases of asparaginase inclusion body formation were of
shorter duration and resulted in formation of small size (100–
200 nm) aggregates in comparison to hGH IBs. In contrast to this,
hGH inclusion body formation started from smaller nuclei and
grown into bigger size with post induction period. Human growth
hormone inclusion bodies were more resistant to proteinase K and
showed solubilization profile in urea like a classical inclusion body
while asparaginase IBs were more susceptible to denaturants and
proteases as contrary to hGH. The post induction period had little
effect on proteolytic susceptibility and chaotropic resistivity of
asparaginase IBs in comparison to hGH IBs. It showed that
increase in post induction period made hGH IBs more resistant to
denaturants and proteases. The molecular arrangement of
misfolded or native-like polypeptides in IB aggregates are
homogenous and uniform from inner core region to peripheral
region. Inclusion body aggregates have amyloid like properties and
consist of higher percentage of b-sheet conformation in compar-
ison to native proteins. The formation of hGH inclusion bodies
during recombinant expression in E. coli involves strong interac-
tions between partially folded, amphipathic or hydrophobic a-
helices. The study showed that there is fundamental difference in
the aggregation behavior, physical and structural characteristics of
asparaginase and hGH inclusion bodies. However, the most
important information is that non-classical or soft inclusion bodies
could be solubilized by low concentration of chaotropes for high
throughput recovery of bioactive proteins. Recently, our group has
also shown recovery of bioactive hGH after solubilization of hGH
inclusion bodies in n-Propanol based mild solubilization agent
[43]. These observations suggest the presence of native-like
secondary structures in inclusion body aggregates. The variations
in size of aggregates of the two proteins may arise due to
differences in their nucleation and growth properties during IB
formation. However, amino acid sequences and intermittent
topologies present in folding intermediates (formed during
expression) can also contribute to the nature of inclusion body
aggregates.
Materials and Methods
Chemicals and Reagents
Culture media ingredients, tryptone and yeast extract were from
Difco Laboratories, India. Tris buffer, Glycine, Isoproppyl b-
thiogalactopyranoside (IPTG), sodium dodecyl sulphate, PMSF,
and deoxy cholic acid were from Amresco, USA. Ammonium
persulphate, acrylamide and bis-acrylamide from Sigma chemi-
cals, USA. TEMED, EDTA, Bromophenol blue from BIO-RAD,
USA. Coomassie brilliant blue R-250 and ampicillin and
kanamycin were from USB Corporation, Cleveland, Ohio. SDS-
PAGE low molecular weight marker was purchased from GE
Healthcare, USA. Micro BCA assay kit was from Pierce, USA.
Urea, proteinase K, Thioflavin-T and Congo Red dyes were from
Sigma Chemical Ltd., USA. Glucose, NaCl, reagents and other
chemicals were from Qualigen, India. Escherichia coli BL21 (DE3)
and M 15 strain were from Novagen, USA. Strain DH5a was
obtained from Invitrogen, USA. Vectors were obtained from
Novagen, USA.
Cloning, expression and isolation of inclusion bodies
To clone hGH without any tag and its signal sequence, the
cDNA fragment coding for hGH was excised with HinfI-HindIII
from pRMhGH. This excised cDNA fragment was lacking the first
18 bp. The18 bp were chemically synthesized with HinfI
overhang at the 39-end and NcoI overhang at the 59-end
[59CATG TTC CCA ACT ATT CCA CTG 39;3 9AAG GGT
TGA TAA GGT GAC TCA59]. This synthetic oligonucleotide
and HinfI-HindIII-digested cDNA fragments were inserted into
NcoI-HindIII-digested pQE-60 expression vector (Qiagen,U.S.A.).
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methionine at the N-terminus under the control of the phage T5
promoter. The NcoI site originally present in pQE-60 was lost
during construction of this plasmid. E. coli M15 cells containing the
recombinant expression plasmid (pQE 60-hGH) were grown in LB
or complex medium in the presence of kanamycin (25 mg/ml) and
ampicillin (50 mg/ml). The cultures were induced with 1 mM
IPTG and were further grown for 4 h. Expression of r-hGH in the
total cell extracts from both uninduced and induced cultures was
checked by SDS-PAGE. L-asparaginase II (ansB) gene was
amplified from the genomic DNA of E. coli K-12 strain (JM109)
using primers (forward) 59GTG CAG CAC ATA TGT TAC CCA
ATA TCA CCA39 and (reverse) 59GGC GGG ATC CTT AGT
ACT GAT TGA AGA39. NdeI and BamHI restriction sites were
incorporated in the primers to facilitate cloning of the structural
asparaginase gene (without its native signal sequence) in the E. coli
expression vector pET14b in fusion with a six histidine tag at the N-
terminus. The resultant recombinant plasmid pET14b-Asp was
sequenced to confirm the asparaginase gene insert. E. coli BL21
(DE3) cells were transformed with recombinant pET14b plasmid
vector to get the expression strain. E. coli strain M15 expressing
recombinant hGH and BL21 (DE3) expressing recombinant L-
asparaginase were grown in LB medium at 37uC for 3.5 hrs.
100 mg/ml ampicillin and 25 mg/ml kanamycin were used in
medium in case of hGH expression and 100 mg/ml ampicillin in
case of asparaginase expression. Cells were induced during mid log
phase of growth with final IPTG concentrationof 1 mM.Cells were
pelleted at 6000 rpm (rotor SLA-3000, Sorvall Revolution) for
10 minutes at 4uC. Supernatant medium was discarded and one
litre culture pellet was resuspended in 20 ml buffer I (50 mM Tris-
HCl, 1 mM EDTA, 1 mM PMSF, pH 8.5) containing egg white
lysozyme (1 mg/ml) and incubated at room temperature for
2 hours. Resuspended cells were sonicated for 10 cycle (1 min
cycle with 1 min gap) using Branson sonifier 450, Germany (probe
diameter13 mm,outputvoltage 60and%dutycycle50).Sonicated
cells were centrifuged at 12000 rpm (SA-300 rotor, Sorvall
Revolution) for 20 minutes at 4uC. Again, supernatant was
discarded and pellet was resuspended in 20 ml buffer I containing
1% Deoxycholic acid (for hGH IBs)and 0.1%Deoxycholic acid (for
asparaginase IBs). Pellets were again sonicated and centrifuged as
described earlier. Pellet was washed twice with buffer I and final
pellet was washed with de-ionized water. Washed pellet was
resuspended in 1 ml 50 mM Tris-HCl buffer, pH 8.5.
Inclusion body purification by sucrose density gradient
ultracentrifugation
Isolated IBs were further purified by sucrose density gradient
ultra centrifugation. Sucrose step gradient was prepared in
ultracentrifuge rotor tubes by drop wise addition of sucrose
solution. 1 ml of each of 80%, followed by 72%, 70%, 68%, 66%,
64%, 62%, and 60% (w/v) of sucrose solution was added from
bottom to top of the tube to prepare the sucrose gradient. 1 ml
inclusion body suspension was added on top of the 60% sucrose
layer in the tube, and centrifuged at 1,20,000 g for 6 hours in a
swinging rotor at 4uC. Inclusion bodies were seen in the sucrose
gradient as a dense layer below impurities. The dense layer was
carefully removed by pipetting without disturbing the other layers
and washed with Milli-Q water. Purity of the inclusion bodies was
checked by 12% SDS-PAGE analysis. Purified inclusion bodies
were used for size analysis.
Solubilization of purified inclusion bodies
Solubilization profile of pure inclusion bodies in urea was
determined by measuring turbidity of solubilized samples at
350 nm. Isolated hGH and asparaginase IBs were solubilized in
50 mM Tris-HCl, 5 mM DTT, pH 8.5 buffers containing
different molar urea (0–8 molar) and left overnight. After
solubilization, turbidities of samples were measured at 350 nm
by spectrophotometer (UV 2450, Shimadzu, Japan).
Asparaginase activity assay
Asparaginase IBs were solubilized in 3 M, 6 M and 8 M urea
for 2 hours. Solubilized samples were centrifuged at 13,000 rpm
for 20 minutes. Supernatants were then refolded by drop-wise
dilution in buffer containing 50 mM Tris-HCl. Asparaginase
activity was assayed using method described by Wriston Jr [44].
Briefly, reaction mixture consists of 50 mM Tris-HCl (pH 8.6) and
8.6 mM L-asparagine was incubated at 37uC for 10 minutes.
Refolded L-asparaginase enzyme solution (10 mg/ml) was added
in reaction mixture and incubated at 37uC. Reaction was stopped
by adding 1.5 M trichloro acetic acid at different time points and
sample was centrifuged and used for estimation of released
ammonia by Nessler’s reagent using ammonium sulphate as
standard. An international unit (IU) of L- asparaginase is defined
as the amount of enzyme required to release one micromole of
ammonia per minute under the condition of the assay at saturating
substrate concentration.
Size analysis of inclusion bodies
Asparaginase and hGH inclusion bodies, isolated and purified at
different time points after induction of E. coli cells, were
homogenized and their size distribution was analyzed by Malvern
Mastersizer Hydro 2000S (Malvern Instruments, USA). Inclusion
body samples were injected into detection chamber with 10%
obscurity and were scanned 10 times. Size distributions of
inclusion bodies were analyzed by plotting a graph between
percentage population and their size of inclusion bodies harvested
at different time points after induction. Inclusion bodies isolated
after different time of induction were purified and analyzed by
transmission electron microscopy. Ultra pure inclusion bodies
obtained by sucrose density gradient ultra centrifugation methods
were homogenized and diluted to 1 mg/ml. 10 ml of the diluted
samples of IBs were placed on carbon-coated copper grids and
dried in a desiccator for 30 minutes. Then grids were washed with
distilled water and stained with 2% (w/v) uranyl acetate for
5 minutes. Morphology and refractive properties of inclusion
bodies were analyzed under transmission electron microscope (Jeol
JSM 35CF, Japan).
Proteolytic digestion of inclusion bodies
Purified hGH and asparaginase inclusion bodies, obtained after
different time points of induction, were subjected to proteolytic
digestion. Inclusion bodies were diluted to 1 OD at 350 nm in
980 ml of 50 mM Tris-HCl, 150 mM NaCl buffer of pH 8.0.
Proteolytic digestion of IBs was initiated by adding 20 ml
proteinase K stock (0.2 mg/ml) to the inclusion body solution (at
4 mg/ml final concentration). Proteolytic digestion was monitored
for 200 minutes (hGH IBs) and 100 minutes (Asparaginase IBs) by
measuring the changes in OD at 350 nm in UV-2450 spectro-
photometer (Shimadzu, Japan).
Amyloid specific assays of inclusion bodies
Asparaginase and hGH IBs were tested for Congo red (CR)
binding by the spectroscopic band shift assay [14]. Inclusion
bodies were diluted in reaction buffer (10 mM sodium phosphate,
pH 7.0 containing 150 mM NaCl) containing 10 mM CR to final
protein concentration of 25 mg/ml. Samples were incubated for
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Absorption spectra were collected together with negative control
solutions of dye in the absence of protein and of protein in absence
of dye on a UV-2450 spectrophotometer (Shimadzu, Japan).
Individual scattering contribution of IBs spectra was subtracted
from their respective samples spectra (dye + protein). The final
reaction mixture for thioflavin-T (Th-T) assay consisted of 50 mg/
ml protein, 10 mM phosphate buffer of pH 7.0, 150 mM NaCl,
and 75 mM Th-T. Samples were kept at room temperature for
10 minutes for thermal equilibration. Fluorescence emission
spectra were recorded from 460 to 600 nm using an excitation
wavelength of 440 nm (Cary Eclipse spectrophotometer, Varian,
Australia). 5 nm slit width was fixed for both excitation and
emission wavelength.
ATR-FTIR spectroscopy of inclusion bodies
Asparaginase and hGH inclusion bodies were purified by
sucrose density gradient method. Inclusion bodies were lyophilized
to remove water. Samples were dried in a Speed-Vac system for
2 hours. The dried samples were spread on BaF2 crystal cells for
spectra acquisition. The structure of dry IB aggregates was
analyzed directly in Bruker Tensor FTIR spectrometer. For each
spectrum (4000 cm
21 to 1000 cm
21), 25 interferograms were
collected and averaged. Second derivatives of the amide I and II
region spectra were used to determine the frequencies at which the
different spectral components were located. These frequencies
were used for assignment of secondary structural contents in
inclusion body proteins.
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